chevron_leftBack
As of 24 April 2025, Roche Holding AG has a market cap of $246.36B USD, ranking #42 globally and #2 in Switzerland. It ranks #6 in the Healthcare sector, and #5 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$246.36BUSD
204.44B CHF
Enterprise Value
$274.6BUSD
227.88B CHF
Revenue (TTM)
$75.19BUSD
62.4B CHF
EBITDA (TTM)
$27.37BUSD
22.72B CHF
Net Income (TTM)
$9.97BUSD
8.28B CHF
EBITDA Margin
36%
Profit Margin
13%
PE Ratio
24.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Thomas Schinecker
open_in_new
Employees
103,249
Founded
1896
Website
roche.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.7% | 2.7% | -16% | -5.2% | -7.8% | 13% |
Upcoming Earnings
Earnings Date
Fri, Apr 25
Tomorrow
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
RO
Roche Holding AG Bearer Shares
ISIN: CH0012032113
Shares Out.:
Shares Outstanding:
106.691M1
Shares Float:
29.011M2
|
276.00 CHF | |
|
ROG
ISIN: CH0012032048
Shares Out.:
Shares Outstanding:
688.71M1
Shares Float:
688.708M2
|
258.10 CHF | |
|
0QOK
ISIN: CH0012032048
Shares Out.:
Shares Outstanding:
688.71M1
Shares Float:
688.708M2
|
258.45 CHF | |
|
0QQ6
Roche Holding AG Bearer Shares
ISIN: CH0012032113
|
266.60 CHF | |
|
0TDF
Roche Holding AG ADR
ISIN: US7711951043
Shares Out.:
Shares Outstanding:
5.51B1
Shares Float:
5.508B2
|
37.77 USD | |
|
RHHBF
Roche Holding AG Bearer Shares
ISIN: CH0012032113
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
340.43 USD | |
|
RHHBY
Roche Holding AG ADR
ISIN: US7711951043
Shares Out.:
Shares Outstanding:
5.51B1
Shares Float:
5.508B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
39.11 USD | |
|
RHHVF
ISIN: CH0012032048
Shares Out.:
Shares Outstanding:
688.71M1
Shares Float:
688.708M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
307.23 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
Country |
|---|---|---|
Novartis AG
SIX: NOVN
|
$207.35B
-16%
172.07B CHF
|
